Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy

Cuylan Z. F. , Meydanli M. M. , Sari M. E. , Akbayir O., Celik H., Dede M., ...More

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, vol.44, no.7, pp.1284-1293, 2018 (SCI-Expanded) identifier identifier identifier


ObjectiveTo identify factors predictive of poor prognosis in women with stage III nonserous epithelial ovarian cancer (EOC) who had undergone maximal or optimal primary cytoreductive surgery (CRS) followed by six cycles of intravenous carboplatin/paclitaxel chemotherapy.